518 related articles for article (PubMed ID: 31443650)
1. Critical combination of initial markers for predicting refractory Mycoplasma pneumoniae pneumonia in children: a case control study.
Choi YJ; Jeon JH; Oh JW
Respir Res; 2019 Aug; 20(1):193. PubMed ID: 31443650
[TBL] [Abstract][Full Text] [Related]
2. Utility of serum ferritin and lactate dehydrogenase as surrogate markers for steroid therapy for Mycoplasma pneumoniae pneumonia.
Kawamata R; Yokoyama K; Sato M; Goto M; Nozaki Y; Takagi T; Kumagai H; Yamagata T
J Infect Chemother; 2015 Nov; 21(11):783-9. PubMed ID: 26298038
[TBL] [Abstract][Full Text] [Related]
3. Management of refractory Mycoplasma pneumoniae pneumonia: utility of measuring serum lactate dehydrogenase level.
Inamura N; Miyashita N; Hasegawa S; Kato A; Fukuda Y; Saitoh A; Kondo E; Teranishi H; Wakabayashi T; Akaike H; Tanaka T; Ogita S; Nakano T; Terada K; Ouchi K
J Infect Chemother; 2014 Apr; 20(4):270-3. PubMed ID: 24486173
[TBL] [Abstract][Full Text] [Related]
4. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia.
Zhou Y; Wang J; Chen W; Shen N; Tao Y; Zhao R; Luo L; Li B; Cao Q
BMC Infect Dis; 2020 Aug; 20(1):633. PubMed ID: 32847534
[TBL] [Abstract][Full Text] [Related]
5. Atopy: a risk factor of refractory mycoplasma pneumoniae pneumonia?
Bao YX; Li J; Tian Y; Liu QH; Bao J
Clin Respir J; 2017 Nov; 11(6):931-934. PubMed ID: 26683420
[TBL] [Abstract][Full Text] [Related]
6. The combination of initial markers to predict refractory Mycoplasma pneumoniae pneumonia in Chinese children: a case control study.
Wen J; Su Y; Sun H; Zhang H; Li H
Respir Res; 2021 Mar; 22(1):89. PubMed ID: 33752670
[TBL] [Abstract][Full Text] [Related]
7. Lactate Dehydrogenase as a Biomarker for Prediction of Refractory Mycoplasma pneumoniae Pneumonia in Children.
Lu A; Wang C; Zhang X; Wang L; Qian L
Respir Care; 2015 Oct; 60(10):1469-75. PubMed ID: 26060318
[TBL] [Abstract][Full Text] [Related]
8. [Clinical features and treatment of refractory Mycoplasma pneumoniae pneumonia unresponded to conventional dose methylprednisolone in children].
Chen L; Liu J; Zhao S; Yang Y; Wu J
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):172-6. PubMed ID: 24824385
[TBL] [Abstract][Full Text] [Related]
9. Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia.
Yoon IA; Hong KB; Lee HJ; Yun KW; Park JY; Choi YH; Kim WS; Lee H; Eun BW; Ahn YM; Cho EY; Cho HJ; Choi EH
BMC Infect Dis; 2017 Jun; 17(1):402. PubMed ID: 28592263
[TBL] [Abstract][Full Text] [Related]
10. Challenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia.
Ding G; Zhang X; Vinturache A; van Rossum AMC; Yin Y; Zhang Y
Eur J Pediatr; 2024 Jul; 183(7):3001-3011. PubMed ID: 38634891
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for the development of post-infectious bronchiolitis obliterans after Mycoplasma pneumoniae pneumonia in the era of increasing macrolide resistance.
Lee E; Young Lee Y
Respir Med; 2020 Dec; 175():106209. PubMed ID: 33186845
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of interleukin-18 levels in pediatric patients with Mycoplasma pneumoniae pneumonia.
Oishi T; Narita M; Matsui K; Shirai T; Matsuo M; Negishi J; Kaneko T; Tsukano S; Taguchi T; Uchiyama M
J Infect Chemother; 2011 Dec; 17(6):803-6. PubMed ID: 21681500
[TBL] [Abstract][Full Text] [Related]
13. Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children.
Tamura A; Matsubara K; Tanaka T; Nigami H; Yura K; Fukaya T
J Infect; 2008 Sep; 57(3):223-8. PubMed ID: 18656264
[TBL] [Abstract][Full Text] [Related]
14. Setting a standard for the initiation of steroid therapy in refractory or severe Mycoplasma pneumoniae pneumonia in adolescents and adults.
Miyashita N; Kawai Y; Inamura N; Tanaka T; Akaike H; Teranishi H; Wakabayashi T; Nakano T; Ouchi K; Okimoto N
J Infect Chemother; 2015 Mar; 21(3):153-60. PubMed ID: 25533771
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of 3 cases with Mycoplasma pneumoniae-associated hemophagocytic syndrome and review of literature].
Lu Z; Yang J; Wang Y; He Y; Bai D; Ma H; Zheng Y
Zhonghua Er Ke Za Zhi; 2014 Oct; 52(10):792-6. PubMed ID: 25537549
[TBL] [Abstract][Full Text] [Related]
16. Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea.
Lee E; Kim CH; Lee YJ; Kim HB; Kim BS; Kim HY; Kim Y; Kim S; Park C; Seo JH; Sol IS; Sung M; Song MS; Song DJ; Ahn YM; Oh HL; Yu J; Jung S; Lee KS; Lee JS; Jang GC; Jang YY; Chung EH; Chung HL; Choi SM; Choi YJ; Han MY; Shim JY; Kim JT; Kim CK; Yang HJ;
BMC Infect Dis; 2020 Feb; 20(1):132. PubMed ID: 32050912
[TBL] [Abstract][Full Text] [Related]
17. Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children.
Shan LS; Liu X; Kang XY; Wang F; Han XH; Shang YX
World J Pediatr; 2017 Aug; 13(4):321-327. PubMed ID: 28130749
[TBL] [Abstract][Full Text] [Related]
18. Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure.
Cheong KN; Chiu SS; Chan BW; To KK; Chan EL; Ho PL
J Microbiol Immunol Infect; 2016 Feb; 49(1):127-30. PubMed ID: 25556047
[TBL] [Abstract][Full Text] [Related]
19. An adult case of severe life-threatening Mycoplasma pneumoniae pneumonia due to a macrolide-resistant strain, Japan: a case report.
Matsumoto M; Nagaoka K; Suzuki M; Konno S; Takahashi K; Takashina T; Ishiguro N; Nishimura M
BMC Infect Dis; 2019 Feb; 19(1):204. PubMed ID: 30819124
[TBL] [Abstract][Full Text] [Related]
20. High Mycoplasma pneumoniae loads and persistent long-term Mycoplasma pneumoniae DNA in lower airway associated with severity of pediatric Mycoplasma pneumoniae pneumonia.
Liu J; Zhao F; Lu J; Xu H; Liu H; Tang X; Yang H; Zhang J; Zhao S
BMC Infect Dis; 2019 Dec; 19(1):1045. PubMed ID: 31823740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
